EUVIMEDEUVIMED entdecken
Crossref

Rhabdomyosarcoma Arising in Inflammatory Rhabdomyoblastic Tumor: A Genetically Distinctive Subtype of Rhabdomyosarcoma

Carina A Dehner, Katherine Geiersbach, Ross Rowsey, Paari Murugan, Stephen M Broski, Jeanne M Meis, Andrew E Rosenberg, Andrew L Folpe

Modern Pathology · 2023

DOI: 10.1016/j.modpat.2023.100131 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Modern Pathology, 2023. Verfasst von Carina A Dehner und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota. Hauptthemen laut MEDLINE: Rhabdomyosarcoma, Soft Tissue Neoplasms, Rhabdomyosarcoma, Embryonal. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 41 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

"Inflammatory rhabdomyoblastic tumor" (IRMT) is a recently coined name for a distinctive soft tissue neoplasm characterized by slow growth, a dense histiocytic infiltrate, scattered, bizarre-appearing tumor cells with morphologic and immunohistochemical evidence of skeletal muscle differentiation, a near-haploid karyotype with retained biparental disomy of chromosomes 5 and 22, and usually indolent behavior. There are 2 reports of rhabdomyosarcoma (RMS) arising in IRMT. We studied the clinicopathologic and cytogenomic features of 6 cases of IRMT with progression to RMS. Tumors occurred in the extremities of 5 men and 1 woman (median patient age, 50 years; median tumor size, 6.5 cm). Clinical follow-up (6 patients: median, 11 months; range 4-163 months) documented local recurrence and distant metastases in 1 and 5 of 6 patients, respectively. Therapy included complete surgical resection (4 patients) and adjuvant/neoadjuvant chemo/radiotherapy (6 patients). One patient died of disease, 4 were alive with metastatic disease, and one was without evidence of disease. All primary tumors contained conventional IRMT. Progression to RMS appeared as follows: (1) overgrowth of monomorphic rhabdomyoblasts with diminished histiocytes, (2) monomorphic spindle cell morphology with variably pleomorphic rhabdomyoblasts and low mitotic activity, or (3) morphologically undifferentiated spindle cell and epithelioid sarcoma. All but one were diffusely desmin-positive, with more limited MyoD1/myogenin expression. All RMS arising in IRMT, either primary or metastatic, demonstrated widespread loss of heterozygosity with retained heterozygosity of chromosomes 5 and 20, and all but one displayed additional gains and losses involving loci containing oncogenes/ tumor suppressor genes, most often CDKN2A and CDKN2B. RMS arising in IRMT have unique clinicopathologic and cytogenomic features, warranting classification as a distinct, potentially aggressive RMS subtype. It should be distinguished from other RMSs, particularly fusion-driven spindle cell RMS and pleomorphic RMS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RhabdomyosarcomaSoft Tissue NeoplasmsRhabdomyosarcoma, EmbryonalMaleFemaleAdultHumansChildMiddle AgedBiomarkers, TumorCell Differentiation

Stichwörter der Autor:innen

CytogenomicsHaploidyInflammatory leiomyosarcomaInflammatory rhabdomyoblastic tumorRhabdomyosarcomaSingle-nucleotide polymorphism

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota.
  • Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, Minnesota.
  • Department of Radiology, Mayo Clinic, Rochester, Minnesota.
  • Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Department of Pathology, Miller School of Medicine, University of Miami, Miami Florida.
  • Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota. Electronic address: folpe.andrew@mayo.edu.

Zitieren

APA

Dehner, C. A., Geiersbach, K., Rowsey, R., Murugan, P., Broski, S. M., Meis, J. M., Rosenberg, A. E., & Folpe, A. L. (2023). Rhabdomyosarcoma Arising in Inflammatory Rhabdomyoblastic Tumor: A Genetically Distinctive Subtype of Rhabdomyosarcoma. Modern Pathology. https://doi.org/10.1016/j.modpat.2023.100131

Vancouver

Dehner CA, Geiersbach K, Rowsey R, Murugan P, Broski SM, Meis JM, et al. Rhabdomyosarcoma Arising in Inflammatory Rhabdomyoblastic Tumor: A Genetically Distinctive Subtype of Rhabdomyosarcoma. Modern Pathology. 2023. doi:10.1016/j.modpat.2023.100131

BibTeX
@article{Dehner2023,
  author = {Dehner, Carina A and Geiersbach, Katherine and Rowsey, Ross and Murugan, Paari and Broski, Stephen M and Meis, Jeanne M and Rosenberg, Andrew E and Folpe, Andrew L},
  title = {Rhabdomyosarcoma Arising in Inflammatory Rhabdomyoblastic Tumor: A Genetically Distinctive Subtype of Rhabdomyosarcoma},
  journal = {Modern Pathology},
  year = {2023},
  doi = {10.1016/j.modpat.2023.100131}
}
Kostenlos starten →